LYVE1

LYVE1 Full Name

lymphatic vessel endothelial hyaluronan receptor 1

LYVE1 Introduction

LYVE-1 is a type I transmembrane glycoprotein belonging to the Link module–containing superfamily, which includes the CD44 family of hyaluronan receptors. It is encoded by the LYVE1 gene and shares approximately 40% amino acid identity with the standard form of CD44, yet its function is uniquely specialized. Structurally, LYVE-1 features an extracellular N-terminal Link domain that mediates high-affinity binding to hyaluronan (HA), a major component of the extracellular matrix. This binding is dependent on specific basic amino acid residues within the Link domain, and interestingly, LYVE-1 can also interact with other glycosaminoglycans such as chondroitin sulfate, albeit with lower affinity. The short cytoplasmic tail lacks any canonical signaling motifs, suggesting that LYVE-1 primarily acts as an adhesion or scavenger receptor rather than a direct signal transducer, though its clustering may facilitate downstream events via associated proteins.

Figure 1.Lymphatic vessel endothelial hyaluronan receptor 1 (lyve-1) gene & protein function map.

Differential Expression Patterns in Tissues
While LYVE1 has long been celebrated as a canonical marker for lymphatic endothelial cells, its expression is not strictly limited to the lymphatic vasculature. In normal adult tissues, abundant LYVE1 staining is observed in liver sinusoidal endothelial cells, splenic red pulp macrophages, and certain subsets of bone marrow stromal cells. During embryonic development, its expression appears transiently in blood vascular endothelium before becoming restricted to developing lymphatic buds. This broader distribution challenges the notion of LYVE1 as an exclusively lymphatic marker, prompting researchers to employ combinatorial approaches with other markers such as PROX1 or PDPN. Moreover, inflammatory conditions can upregulate LYVE1 on activated macrophages, complicating its interpretative value in pathological specimens.

Functional Participation in Leukocyte Trafficking
Beyond its established role as a hyaluronan receptor, LYVE1 actively participates in the transmigration of leukocytes across lymphatic endothelial barriers. It mediates the initial tethering and rolling of myeloid cells, particularly macrophages and dendritic cells, along the luminal surface of lymphatic vessels under shear flow conditions. This adhesion process is facilitated by the binding of hyaluronan-rich glycocalyx components presented on the leukocyte surface, creating a molecular bridge between circulating cells and the endothelium. Subsequently, LYVE1 engagement triggers cytoskeletal rearrangements in endothelial cells, promoting the formation of transient docking structures that aid diapedesis. This function positions LYVE1 as a key regulator of immune surveillance and antigen transport from peripheral tissues to draining lymph nodes.

Alternate Names for LYVE1

LYVE1; lymphatic vessel endothelial hyaluronan receptor 1; Xlkd1; Lyve-1; Crsbp-1; 1200012G08Rik; lymphatic vessel endothelial hyaluronic acid receptor 1; extra cellular link domain-containing 1; lymphatic vessel endothelial HA recptor-1; lymphatic vessel endothelial HA receptor-1